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Abstract
The impact of routine, opt-out HIV testing programs in clinical settings is inconclusive. The 
objective of this study was to estimate the impact of an expanded, routine HIV testing program in 
North Carolina sexually transmitted disease (STD) clinics on HIV testing and case detection.
Adults aged 18–64 who received an HIV test in a North Carolina STD clinic July 1, 2005 through 
June 30, 2011 were included in this analysis, dichotomized at the date of implementation on 
November 1, 2007. HIV testing and case detection counts and rates were analyzed using 
interrupted time series analysis, and Poisson and multilevel logistic regression.
Pre-intervention, 426 new HIV-infected cases were identified from 128,029 tests (0.33%), whereas 
816 new HIV-infected cases were found from 274,745 tests post-intervention (0.30%). Pre-
intervention, HIV testing increased by 55 tests per month (95% confidence interval [CI]: 41, 72), 
but only 34 tests per month (95% CI: 26, 42) post-intervention. Increases in HIV testing rates were 
most pronounced in females and non-Hispanic whites. A slight pre-intervention decline in case 
detection was mitigated by the intervention (mean difference [MD]=0.01; 95% CI: −0.02, 0.05). 
Increases in case detection rates were observed among females and non-Hispanic blacks.
The impact of a routine HIV screening in North Carolina STD clinics was marginal, with the 
greatest benefit among persons not traditionally targeted for HIV testing. The use of a pre-
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intervention comparison period identified important temporal trends that otherwise would have 
been ignored.
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INTRODUCTION
In the United States, approximately 20% of people infected with HIV are unaware of their 
HIV-infected status; disease transmission from these individuals accounts for 50% of new 
HIV infections.1,2 Effective HIV testing programs are essential to identify HIV-infected 
persons and enroll them in medical care, thereby slowing disease progression and reducing 
further HIV transmission.3,4 In 2006, the Centers for Disease Control and Prevention (CDC) 
recommended routine, opt-out HIV testing in clinical settings.5 From 2007 through 2010, 
testing programs performed 2.8 million CDC-funded HIV tests and identified over 18,000 
new HIV-infected cases.6 However, these cases represent only a small fraction of the 
approximately 150,000 new HIV infections acquired over the same period.7
Routine, opt-out HIV testing can be feasible to implement and acceptable to both patients 
and providers.8,9 Although the number of HIV tests performed increases with the 
introduction of an expanded HIV testing program, the impact on the identification of new 
HIV-infected cases has been inconclusive. While some expanded HIV testing programs 
showed an increase in case detection, others showed a decrease or no change.9–16 These 
programs have been limited by small numbers and a focus on clinical settings with minimal 
pre-implementation HIV testing.
We conducted a statewide, before-after analysis of a routine, opt-out expanded HIV testing 
program in all 102 North Carolina sexually transmitted disease (STD) clinics. North 
Carolina, like many southeastern states, bears a large burden of HIV infection and STDs.17 
The program’s impact was measured by the number of HIV tests performed and new 
detection of HIV-infected cases. We aimed to determine the incremental impact of an 
expanded HIV testing program in a clinical setting with a high baseline level of HIV testing.
MATERIALS AND METHODS
Study Population & Setting
This study included all patients aged 18–64 years who were tested for HIV in North 
Carolina’s 102 county-level STD clinics from July 1, 2005 through June 30, 2011. Non-
North Carolina residents and patients lacking an HIV test result were excluded from analysis 
(n=1,149 of 414,015 HIV tests).
Patients who agreed to HIV testing had blood samples drawn and, along with a form with 
demographic information, processed at the North Carolina State Laboratory for Public 
Health (SLPH). At the SLPH, the samples were tested for HIV antibodies using a 3rd 
generation enzyme immunoassay (EIA); all reactive samples were confirmed via Western 
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Blot. EIA-negative samples were pooled for acute HIV testing by polymerase chain reaction 
for viral RNA. Test results and demographic information were entered into the SLPH HIV 
testing database; results were provided to the patient in a follow-up STD clinic visit. If no 
prior HIV-positive record existed for a patient, the patient was entered into the state HIV 
surveillance database, the electronic HIV/AIDS reporting system (eHARS), as a new HIV-
infected case. Patient-level data were collected by linking the SLPH and eHARS electronic 
surveillance databases by a unique HIV testing identifier.
Intervention: Expanded HIV Testing Program
The North Carolina Expanded HIV Testing Program was introduced in November 2007, 
focusing on routine, opt-out HIV testing in clinical settings, regardless of patient risk profile 
or HIV testing history. Because of the high-risk patient population, HIV testing was already 
common in STD clinics.18 In this pre-intervention period, opt-in, risk-based HIV testing was 
performed, with a focus on patients with sexual exposure to HIV, men who had sex with 
men, or no recent history of HIV testing. The opt-out, routing HIV testing intervention was 
disseminated and sustained through webinars, lectures, notices to health departments, 
contract addendums, and state-wide conferences attended by STD clinic and health 
department employees.
Exposure Definition
The intervention was implemented on November 1, 2007. We assumed a lag period of 3 
months from the start date of the intervention to full implementation. Therefore, in 
regression analyses, persons tested for HIV prior to November 1, 2007 were considered 
“unexposed” to the expanded HIV testing program; persons tested for HIV after February 1, 
2008 were considered “exposed”. This lag period was varied from 0 to 6 months in 
sensitivity analyses.
Outcome Assessment
Two primary outcomes were evaluated: HIV testing and the new detection of HIV-infected 
cases. HIV testing was measured as the number of HIV tests performed, and as the HIV 
testing rate per 100,000 persons, based on annual intercensal population estimates.19 Case 
detection was measured as both the number of new HIV-infected cases and HIV-positivity 
per 1000 HIV tests. A new case of HIV infection was defined as a patient with a positive 
HIV test in the same calendar month as the person’s diagnosis date in eHARS. This window 
period accounted for possible reporting delays and uncertainty regarding patients who 
lacked an exact date of HIV diagnosis; these patients were assigned to the 15th day of their 
diagnosis month. This approximation recoded 69 HIV-infected cases as newly-diagnosed, 
when they otherwise would have been considered a previous diagnosis (3.3% of patients 
with a positive test result, 0.009% of the total study population).
Patient demographics at the time of HIV testing were abstracted from the SLPH database 
and included gender (male, female), race/ethnicity (non-Hispanic white, non-Hispanic black, 
Hispanic, other), and age. STD clinics were categorized by population density (<199, 200–
399, 400–599, ≥600 persons per square mile), metropolitan/micropolitan statistical areas 
(MeSA, MiSA, neither), and proportion of the county living below the poverty line (<15%, 
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15–19.9%, 20–24.9%, ≥25%).20 A baseline HIV rate was calculated as the average number 
of reported HIV cases per 100,000 from 2005 through 2007 (categorized for analysis as 0–
4.9, 5–9.9, 10–14.9, ≥15).21 A dichotomous variable identified the presence or absence of an 
in-house HIV clinic; STD clinics with an in-house HIV clinic were Durham, Mecklenberg, 
and Wake Counties.
Statistical Analysis
Descriptive analyses were used to examine trends in HIV testing and case detection before 
and after the introduction of the intervention. Multivariate regression analyses were 
conducted with two distinct approaches: interrupted time series analyses and multilevel 
modeling. Given the small proportion of study subjects missing individual-level covariate 
information (age, sex, race/ethnicity; n=9961, 2.4% of tests with a valid HIV test result), a 
complete case analysis was conducted. An individual HIV test, not patient, was the unit of 
analysis. The final analysis cohort included 402,774 unique HIV tests performed over 72 
monthly time points.
Interrupted time series methods, specifically autoregressive integrated moving average 
(ARIMA) models, were applied to serial monthly cross-sections of HIV testing data. 
Because HIV testing in one month is dependent on testing in the prior month and influences 
testing in subsequent months, we used ARIMA models to account for underlying temporal 
correlation between parameter estimates and their residual errors. This method describes the 
trend (slope) of an outcome over time, and how this trend changes with the introduction of 
an intervention. We identified parameters representing the (a) pre-intervention intercept, (b) 
pre-intervention slope, (c) overall post-intervention slope, and (d) change in slope 
attributable to the intervention. Mean differences (MDs) and corresponding 95% confidence 
intervals (95% CIs) were calculated for all patients and stratified by patient- and clinic-level 
characteristics.
To evaluate the overall association between the intervention and the rate of HIV testing per 
100,000 population, we used Poisson regression to calculate rate ratios (RRs) and 95% CIs. 
The rate denominator was created from annual intercensal population estimates; STD clinic-
specific denominator data were not available. To broadly adjust for time trends, models were 
also adjusted for calendar year.
Fixed-slope random-intercept multilevel regression models were used to evaluate the 
intervention’s impact on HIV case detection, while accounting for clustering by STD clinic. 
Intercepts were varied to accommodate differential HIV risks by county. In sensitivity 
analyses, we compared the random-intercept models to models without county-level 
clustering. Since HIV-positivity is a rare outcome, we used logistic regression to calculate 
odds ratios (ORs) and corresponding 95% CIs.
With an externally-determined time point as the demarcation between the exposed and 
unexposed periods, measured covariates were not associated with the “exposure” 
(intervention) and could not be confounders. To address potential differences in the covariate 
distributions over time, the multilevel model was adjusted for patient- and clinic-level 
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characteristics (Table 1). An indicator for calendar year was added to broadly account for 
underlying time trends.
All analyses were conducted using SAS version 9.2 (SAS Institute, Cary, NC).22 This study 




Pre-intervention, 128,029 HIV tests were performed, of which 426 (0.33%) were new HIV-
infected cases. In the post-intervention period, 274,745 HIV tests were performed, detecting 
816 (0.30%) new HIV-infected cases (Table 1).
Just over half of the tested patients were female, although more female patients were tested 
in the post-intervention phase (51.8% vs. 54.9%). The proportion of non-Hispanic black 
patients increased from 53.18% to 58.40%, while the proportion of non-Hispanic white, 
Hispanic, and other race/ethnicity decreased. No changes in the age distribution of patients 
receiving an HIV test or in clinic-level characteristics were observed between the pre- and 
post-intervention periods.
Number of HIV Tests Performed
In July 2005, the baseline number of HIV tests performed per month was 3832. Prior to the 
intervention, the number of HIV tests performed per month increased at a rate of 55 tests per 
month (95% CI: 41, 72), or an increase of 0.81 tests per 100,000 persons per month (Figure 
1a–b). Post-intervention, the monthly increase in the number of tests slowed to 34 tests per 
month (95% CI: 26, 42), or an increase of 0.46 tests per 100,000 persons per month. 
Compared with the monthly rate of HIV testing predicted in the absence of the intervention, 
the monthly rate of HIV testing attributable to the intervention decreased by 20 tests per 
month (95% CI: −37, −5) or −0.35 tests per 100,000 persons per month.
This overall trend in HIV testing was driven by specific demographic subpopulations (Table 
2). Decreases in the rate of HIV testing per 100,000 population per month attributable to the 
intervention were observed among males (MD= −0.45, 95% CI: −0.70, −0.21), non-Hispanic 
blacks (MD= −1.57, 95% CI: −2.34, −0.80), Hispanics (MD= −1.55, 95% CI: −2.19, −0.92), 
and patients in the youngest age categories (18–24 years; MD= −1.34, 95% CI: −2.07, 
−0.61; 25–34 years: MD= −0.54, 95% CI: −1.03, −0.05). Decreases in the rate of HIV 
testing per month attributable to the intervention were also pronounced in clinics located in 
counties of high population density (MD= −0.63, 95% CI: −1.0, −0.25) and high baseline 
HIV case rates (MD= −0.74, 95% CI: −1.1, −0.40).
Unadjusted Poisson models identified an increase in the rate of HIV testing associated with 
the intervention (RR=1.33; 95% CI: 1.32, 1.34). However, after adjustment for calendar 
year, the association was inverted (RR=0.88; 95% CI: 0.85, 0.91) and in agreement with the 
interrupted time series results.
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The baseline number of new HIV-infected cases detected was 13.82 per month (95% CI: 
10.82, 16.82), or 3.59 cases per 1,000 HIV tests per month (95% CI: 3.05, 4.12; Figure 1c–
d). Little temporal trend in HIV-positivity per 1000 tests per month was observed in either 
the pre- or post-intervention time periods (pre-intervention MD= −0.02; 95% CI: −0.05, 
0.02; post-intervention MD=0.00, 95% CI: −0.02, 0.02).
Despite the lack of a significant trend in HIV-positivity, the expanded HIV testing program 
did slightly mitigate the negative slope observed prior to the intervention (MD=0.01, 95% 
CI: −0.02, 0.05; Table 3). This mitigation was driven by increases in monthly case detection 
rates attributable to the intervention among females (MD=0.03, 95% CI: 0.01, 0.07) and 
non-Hispanic black patients (MD=0.05, 95% CI: 0.00, 0.10). Slight increases in the rate of 
case detection per month attributable to the intervention were also observed in clinics 
without an in-house HIV clinic (MD=0.03, 95% CI: −0.02, 0.07), and in counties with 
moderate levels of poverty and high baseline rates of HIV.
Based on the unadjusted multilevel regression model, the introduction of the expanded HIV 
testing program was associated with a 0.11% reduction in HIV-positivity (OR=0.89, 95% 
CI: 0.79, 1.00; Table 4). The inclusion of patient-level covariates slightly attenuated this 
association, but did not alter precision (OR=0.93, 95% CI: 0.82, 1.05). Adjustment of the 
multilevel model for calendar year attenuated the observed association completely to the null 
(OR=1.02, 95% CI: 0.69, 1.52) and adversely effected precision.
DISCUSSION
Despite the CDC’s recommendation for routine, opt-out HIV testing in clinical settings, the 
impact of expanded HIV testing programs is unclear.5,9–16 We evaluated HIV testing and 
case detection of a routine, opt-out HIV testing program in North Carolina STD clinics using 
a before-after intervention analysis. Due to a consistent increase in HIV testing prior to the 
intervention, the incremental impact of the expanded HIV testing program was minimal. 
This pre-intervention increase in testing can likely be attributed to an emphasis on integrated 
HIV and STD prevention by the North Carolina Division of Public Health since the early 
2000s. However, changes to the North Carolina Administrative Code were necessary to 
allow for implementation of routine, opt-out HIV testing in clinical settings.
In the post-intervention phase, the monthly rate of HIV testing increased, but at a slower rate 
than before the intervention. This attenuation was driven primarily by a decreased rate of 
HIV testing attributable to the intervention among patients regularly targeted for testing 
(males, non-Hispanic blacks, Hispanics, younger patients) but an increased rate of testing 
attributable to the intervention in populations not traditionally considered at high-risk for 
HIV (females, non-Hispanic whites).7,23
Although the change in HIV testing rates attributable to the intervention among traditionally 
high-risk patients decreased, the overall rate of HIV testing per month continued to increase. 
HIV testing is an outcome bounded by the size and capacity of the STD clinic and cannot 
increase infinitely. By expanding HIV testing services, we believe that the intervention will 
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eventually allow for a higher maximum level of HIV testing to be reached than would have 
been observed without the intervention.
Among Hispanics, the overall post-intervention rate of HIV testing decreased. This result is 
concerning: in the Hispanic community, HIV prevalence is high and many barriers 
complicate HIV prevention.24,25 However, underlying changes in the migrant Hispanic 
population due to poor employment in the economic downturn in 2008, which coincided 
with the post-intervention period, could explain this result. If the overall population of 
migrant Latino workers decreased, they would be removed disproportionately from the 
numerator of STD clinic clients but not from the intercensal population-based denominator, 
which could artificially decrease HIV testing rates.
Since the greatest increase in HIV testing was among persons at lower risk for HIV 
acquisition, the incremental increases in case detection were minimal. This minimal impact 
indicates that providers were already successfully identifying HIV-infected persons without 
the intervention. Increases in case detection rates attributable to the intervention were 
observed in populations with increased HIV testing (females) and populations that reflect 
HIV epidemic trends in North Carolina (non-Hispanic blacks).
The small magnitude of the increase in HIV testing is consistent with evaluations of HIV 
testing programs in other settings with high baseline levels of HIV testing. In a Denver STD 
clinic, HIV testing increased 1.2% because 79% of patients tested for syphilis were already 
being tested for HIV before the intervention.10 Expectations of an HIV testing intervention’s 
magnitude should be tempered by the limits of the setting, which can be dictated by pre-
existing HIV testing and case detection levels. In contrast to the STD clinic setting, an opt-
out HIV testing program in a North Carolina emergency department with low pre-
intervention levels of HIV testing during this same time period resulted in a 173% increase 
in HIV testing.26
The impact of expanded HIV testing programs on case detection is inconclusive. 
Interventions have led to both increases and decreases in case detection.9–16 By examining 
the trajectory of case detection for over 2 years prior to the intervention, we were able to 
detect a declining pre-intervention trend. This decline was followed by a steady rate of case 
detection during the post-intervention phase, driven by increased diagnoses in certain 
population groups.
Nearly all extant evaluations of HIV testing programs reduced the pre-intervention level of 
HIV testing and case detection to a cross-sectional measure. A program in San Francisco 
was evaluated with a dynamic pre-intervention comparison, but was implemented in an 
urban setting with a low level of pre-intervention HIV testing and lacked generalizability.16 
A static measure of baseline HIV testing would not adequately capture pre-existing trends in 
HIV testing or case detection. In our evaluation, using a cross-sectional or aggregate 
measure of HIV testing without adjusting for calendar year overestimated the impact of an 
HIV testing intervention. An aggregate measure of case detection underestimated the impact 
of the intervention, even showing a spurious negative association.
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Interrupted time series and multilevel regression analyses answer complementary questions. 
Interrupted time series analysis addresses the change in the rate of an outcome over time and 
is an ecologic method; the unit of analysis is the cross-sectional calendar month. Although 
we urge caution in the over-interpretation of ecologic analyses, the agreement between the 
interrupted time series and multilevel regression models including calendar year strengthens 
our confidence in the interrupted time series results. We could not directly account for 
unmeasured covariates, such as changing perceptions of HIV, HIV-related stigma, and 
shifting disease dynamics. However, our study’s “quasi-experimental” design should 
account for many unmeasured covariates.
The use of routinely-collected public health surveillance data allowed us to evaluate this 
intervention throughout North Carolina. This rich data source led to a larger study 
population than would have been feasible in a standard research environment or if analyses 
were restricted to a single clinical facility. However, surveillance data are not collected for 
research purposes and the completeness and accuracy of records and data elements cannot 
be verified.
Despite the disproportionately high burden of HIV in the southeastern United States, this 
study is the first to evaluate an expanded HIV testing program in the region using a 
comparison group.27–30 HIV prevention interventions in the South face unique challenges 
due to the high rates of comorbid conditions, socioeconomic disparities, and a stark contrast 
between urban and rural areas, which contribute to HIV-related stigma and difficulty 
accessing HIV medical care.31 County-level STD clinics play a crucial role in HIV 
prevention; within the North Carolina State Laboratory for Public Health, STD clinics 
account for 36% of HIV tests and nearly 50% of new HIV diagnoses.25
In North Carolina STD clinics, the introduction of a routine, opt-out expanded HIV testing 
program did not significantly alter the trajectory of HIV testing or case detection. Given the 
bounded nature of these outcomes, these results are not surprising. We believe that, due to 
the increased population eligible for HIV testing, this intervention allowed for the HIV 
testing saturation point to settle at higher level than would be observed without the 
intervention. We also identified slight increases in case detection that mitigated a pre-
intervention decline in identification of new HIV-infected cases. As HIV testing of the 
highest-risk populations was already very successful in the STD clinics, the incremental 
impact of expanding testing to lower-prevalence populations was marginal.
Acknowledgments
Support: This project was supported, in part, by an NRSA predoctoral training grant (T32-AI070114) from the 
National Institute of Allergy and Infectious Diseases, an NRSA postdoctoral training grant (T32-MH19985) from 
the National Institute of Mental Health, and Centers for Disease Control and Prevention PS 12-1201 
(Comprehensive Human Immunodeficiency Virus [HIV] Prevention Programs for Health Departments).
North Carolina Division of Public Health staff, including Evelyn Foust, Jacquelyn Clymore, Aaron Fleischauer, Del 
Williams, Vicky Mobley, Janet Alexander, Pete Moore, Jan Scott, and Lynne Sampson; all STD clinic staff and 
patients
Klein et al. Page 8














1. Hall HI, Holtgrave DR, Maulsby C. HIV transmission rates from persons living with HIV who are 
aware and unaware of their infection. AIDS. Apr 24; 2012 26(7):893–896. [PubMed: 22313960] 
2. Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV 
care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 
Mar; 2011 52(6):793–800. [PubMed: 21367734] 
3. Castilla J, Del Romero J, Hernando V, Marincovich B, Garcia S, Rodriguez C. Effectiveness of 
highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J Acquir Immune 
Defic Syndr. Sep 1; 2005 40(1):96–101. [PubMed: 16123689] 
4. Hogg RS, Heath KV, Yip B, et al. Improved survival among HIV-infected individuals following 
initiation of antiretroviral therapy. JAMA. Feb 11; 1998 279(6):450–454. [PubMed: 9466638] 
5. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of 
adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. Sep 22; 
2006 55(RR-14):1–17. quiz CE11-14. 
6. Results of the Expanded HIV Testing Initiative--25 jurisdictions, United States, 2007–2010. 
MMWR Morb Mortal Wkly Rep. Jun 24; 2011 60(24):805–810. [PubMed: 21697804] 
7. Prejean J, Song R, Hernandez A, et al. Estimated HIV incidence in the United States, 2006–2009. 
PLoS One. 2011; 6(8):e17502. [PubMed: 21826193] 
8. White DA, Scribner AN, Martin ME, Tsai S. A Comparison of Patient Satisfaction with Emergency 
Department Opt-In and Opt-Out Rapid HIV Screening. AIDS Res Treat. 2012; 2012:904916. 
[PubMed: 22400107] 
9. Haukoos JS, Hopkins E, Conroy AA, et al. Routine Opt-Out Rapid HIV Screening and Detection of 
HIV Infection in Emergency Department Patients. Jama-Journal of the American Medical 
Association. 2010; 304(3):284–292.
10. Brooks L, Rietmeijer CA, McEwen D, Subiadur JA, Mettenbrink CJ. Normalizing HIV Testing in 
a Busy Urban Sexually Transmitted Infections Clinic. Sexually Transmitted Diseases. 2009; 36(3):
127–128. [PubMed: 19174728] 
11. Das-Douglas M, Zetola NM, Klausner JD, Colfax GN. Written informed consent and HIV testing 
rates: The San Francisco experience. American Journal of Public Health. 2008; 98(9):1544–1545. 
[PubMed: 18633069] 
12. Goetz MB, Hoang T, Bowman C, et al. A system-wide intervention to improve HIV testing in the 
Veterans Health Administration. Journal of General Internal Medicine. 2008; 23(8):1200–1207. 
[PubMed: 18452045] 
13. Nayak SU, Welch ML, Kan VL. Greater HIV testing after Veterans Health Administration policy 
change: the experience from a VA Medical Center in a high HIV prevalence area. J Acquir 
Immune Defic Syndr. Jun 1; 2012 60(2):165–168. [PubMed: 22627183] 
14. West-Ojo T, Samala R, Griffin A, et al. Expanded HIV Testing and Trend in Diagnoses of HIV 
Infection - District of Columbia, 2004–2008. Morbidity and Mortality Weekly Report. 2010; 
59(24):737–741. [PubMed: 20577154] 
15. White DA, Scribner AN, Vahidnia F, et al. HIV screening in an urban emergency department: 
comparison of screening using an opt-in versus an opt-out approach. Ann Emerg Med. Jul; 2011 
58(1 Suppl 1):S89–95. [PubMed: 21684416] 
16. Zetola NM, Grijalva CG, Gertler S, et al. Simplifying Consent for HIV Testing Is Associated with 
an Increase in HIV Testing and Case Detection in Highest Risk Groups, San Francisco January 
2003–June 2007. Plos One. 2008; 3(7)
17. Prejean J, Tang T, Irene Hall H. HIV Diagnoses and Prevalence in the Southern Region of the 
United States, 2007–2010. J Community Health. Nov 22.2012 
18. Mayer KH. Sexually transmitted diseases in men who have sex with men. Clin Infect Dis. Dec; 
2011 53(Suppl 3):S79–83. [PubMed: 22080272] 
19. Intercensal Population Estimates. U.S. Census Bureau; 
20. [Accessed Jan 3, 2013] North Carolina QuickLinks. http://quickfacts.census.gov/qfd/states/
37000lk.html
Klein et al. Page 9













21. North Carolina 2007 HIV/STD Surveillance Report. Raleigh, NC: North Carolina Division of 
Public Health, HIV/STD Prevention & Care Branch; 2008. 
22. SAS [computer program]. Version 9.2. Cary, NC: SAS Institute, Inc; 2008. 
23. Lansky A, Brooks JT, DiNenno E, Heffelfinger J, Hall HI, Mermin J. Epidemiology of HIV in the 
United States. J Acquir Immune Defic Syndr. Dec; 2010 55(Suppl 2):S64–68. [PubMed: 
21406989] 
24. Painter TM. Connecting the dots: when the risks of HIV/STD infection appear high but the burden 
of infection is not known--the case of male Latino migrants in the southern United States. AIDS 
Behav. Mar; 2008 12(2):213–226. [PubMed: 17373586] 
25. North Carolina Epidemiologic Profile for HIV/STD Prevention & Care Planning. State of North 
Carolina Department of Health & Human Services, Division of Public Health, Epidemiology 
Section, Communicable Disease Branch; 2011. 
26. Hoots BE, Klein PW, Martin IBK, et al. Implementation of a Collaborative HIV Testing Model 
between an Emergency Department and Infectious Disease Clinic. J Acquir Immune Defic Syndr. 
in press. 
27. Sattin RW, Wilde JA, Freeman AE, Miller KM, Dias JK. Rapid HIV testing in a southeastern 
emergency department serving a semiurban-semirural adolescent and adult population. Ann Emerg 
Med. Jul; 2011 58(1 Suppl 1):S60–64. [PubMed: 21684410] 
28. Weis KE, Liese AD, Hussey J, et al. A Routine HIV Screening Program in a South Carolina 
Community Health Center in an Area of Low HIV Prevalence. Aids Patient Care and Stds. 2009; 
23(4):251–258. [PubMed: 19281345] 
29. Copeland B, Shah B, Wheatley M, Heilpern K, del Rio C, Houry D. Diagnosing HIV in men who 
have sex with men: an emergency department’s experience. AIDS Patient Care STDS. Apr; 2012 
26(4):202–207. [PubMed: 22356726] 
30. MacGowan R, Margolis A, Richardson-Moore A, et al. Voluntary Rapid Human 
Immunodeficiency Virus (HIV) Testing in Jails. Sexually Transmitted Diseases. 2009; 36(2):S9–
S13. [PubMed: 17724428] 
31. Reif S, Geonnotti KL, Whetten K. HIV Infection and AIDS in the Deep South. Am J Public 
Health. Jun; 2006 96(6):970–973. [PubMed: 16670228] 
Klein et al. Page 10














Interrupted Time Series Analysis of Monthly Trends in (a) the Number of HIV Tests, (b) the 
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Table 1
Demographic and Clinic-Level Characteristics of Persons Tested for HIV in North Carolina STD Clinics, July 











 New Positive 1,242 (0.31) 426 (0.33) 816 (0.30)
 Not New Positive 401,532 (99.69) 127,603 (99.67) 273,929 (99.70)
Patient Covariates
Gender
 Male 185,714 (46.11) 61,743 (48.23) 123,971 (45.12)
 Female 217,060 (53.89) 66,286 (51.77) 150,774 (54.88)
Race/Ethnicity
 White Non-Hispanic 116,230 (28.86) 39,342 (30.73) 76,888 (27.99)
 Black Non-Hispanic 228,538 (56.74) 68,081 (53.18) 160,457 (58.40)
 Hispanic 35,126 (8.72) 11,113 (8.68) 24,013 (8.74)
 Other 22,880 (5.68) 9,493 (7.41) 13,387 (4.87)
Age (years)
 18–24 179,780 (44.64) 56,961 (44.49) 122,819 (44.70)
 25–34 129,717 (32.21) 40,803 (31.87) 88,914 (32.36)
 35–44 57,295 (14.23) 18,908 (14.77) 38,387 (13.97)
 45–64 35,982 (8.93) 11,357 (8.87) 24,625 (8.96)
Clinic Covariates
Metropolitan Status*
 Metropolitan 300,266 (74.55) 96,327 (75.24) 203,939 (74.23)
 Micropolitan 81,054 (20.12) 25,427 (19.86) 55,627 (20.25)
 Neither 21,454 (5.33) 6,275 (4.9) 15,179 (5.52)
Population Density#
 <199 135,938 (33.75) 42,106 (32.89) 93,832 (34.15)
 200–399 81,262 (20.18) 26,025 (20.33) 55,237 (20.1)
 400–599 31,048 (7.71) 10,602 (8.28) 20,446 (7.44)
 ≥600 154,526 (38.37) 49,296 (38.5) 105,230 (38.3)
% Below Poverty Line
 <15% 70,298 (17.45) 23,275 (18.18) 47,023 (17.12)
 15–19.9% 250,865 (62.28) 79,907 (62.41) 170,958 (62.22)
 20–24.9% 59,706 (14.82) 17,772 (13.88) 41,934 (15.26)
 ≥25% 21,905 (5.44) 7,075 (5.53) 14,830 (5.4)
In-House HIV Clinic
 Yes 83,850 (20.82) 27,603 (21.56) 56,247 (20.47)
 No 318,924 (79.18) 100,426 (78.44) 218,498 (79.53)
Baseline HIV Rate (2005–2007)^
 0–4.9 18,353 (4.56) 5,912 (4.62) 12,441 (4.53)























 5–9.9 62,317 (15.47) 19,975 (15.6) 42,342 (15.41)
 10–14.9 78,829 (19.57) 25,595 (19.99) 53,234 (19.38)
 ≥15 243,275 (60.40) 76,547 (59.79) 166,728 (60.68)
*
Defined by the US Census Bureau’s metropolitan and micropolitan statistical areas
^
Calculated as the average reported HIV case rate per 100,000 population 2005–2007
#
per square mile
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Table 2
Monthly Change in the Rate of HIV Tests per 100,000 Population in North Carolina STD Clinics Attributable 
to the North Carolina Expanded HIV Testing Program, July 2005–June 2011
*
MD: Mean Difference, 95% CI: 95% confidence intervals
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Table 3
Monthly Change in the Rate of New HIV-Positivity per 1,000 HIV Tests Performed in North Carolina STD 
Clinics Attributable to the North Carolina Expanded HIV Testing Program, July 2005–June 2011
*
MD: Mean Difference, 95% CI: 95% confidence intervals
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Table 4
Overall Impact of North Carolina Expanded HIV Testing Program on HIV-Positivity using County-Specific 







 Post-Intervention 0.90 (0.80, 1.01) 0.88 (0.64, 1.21)
 Pre-Intervention 1.00 1.00
Patient Covariates^
 Post-Intervention 0.92 (0.82, 1.04) 0.89 (0.65, 1.23)
 Pre-Intervention 1.00 1.00
Clinic Covariates#
 Post-Intervention 0.90 (0.80, 1.01) 0.88 (0.64, 1.21)
 Pre-Intervention 1.00 1.00
Patient + Clinic Covariates
 Post-Intervention 0.92 (0.82, 1.04) 0.89 (0.65, 1.23)
 Pre-Intervention 1.00 1.00
Year
 Post-Intervention 1.13 (0.57, 2.23) 1.02 (0.69, 1.52)
 Pre-Intervention 1.00 1.00
Patient Covariates + Year
 Post-Intervention 1.16 (0.59, 2.28) 1.04 (0.70, 1.55)
 Pre-Intervention 1.00 1.00
Clinic Covariates + Year
 Post-Intervention 1.12 (0.57, 2.21) 1.02 (0.68, 1.51)
 Pre-Intervention 1.00 1.00
Patient + Clinic Covariates + Year
 Post-Intervention 0.92 (0.82, 1.04) 0.89 (0.65, 1.23)
 Pre-Intervention 1.00 1.00
OR: odds ratio; 95% CI: 95% confidence interval
^
Patient covariates include gender, race/ethnicity, and age
#
Clinic covariates include metropolitan status, population density, % below poverty line, affiliated HIV clinic, and baseline HIV rate
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